<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00765505</url>
  </required_header>
  <id_info>
    <org_study_id>0405764</org_study_id>
    <secondary_id>5R01AG021961</secondary_id>
    <nct_id>NCT00765505</nct_id>
  </id_info>
  <brief_title>Muscle Lipid and Insulin Resistance in the Elderly</brief_title>
  <acronym>MIRA</acronym>
  <official_title>Muscle Lipid and Insulin Resistance in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will provide novel information concerning the ability of exercise to enhance the&#xD;
      capacity for oxidative metabolism of fatty acids and improve insulin resistance in older&#xD;
      adults who are at high risk for the development of type 2 diabetes. Ultimately this may help&#xD;
      identify mechanisms and therapeutic targets implicated in skeletal muscle metabolic&#xD;
      dysregulation. The proposed study is to conduct a randomized controlled exercise training&#xD;
      intervention trial in older men and women. In addition, the response to exercise in these&#xD;
      subjects will be compared to those of highly endurance-trained, age-matched athletes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis and Specific Aims:&#xD;
&#xD;
        1. To determine whether aerobic exercise improves both skeletal muscle fat distribution and&#xD;
           insulin sensitivity of older men and women. We will test two hypotheses.&#xD;
&#xD;
           i. Physical exercise in older adults will decrease the amount of fat interspersed within&#xD;
           muscle, specifically the fat between muscle groups (intermuscular adipose tissue) as&#xD;
           well as decrease specific lipid metabolites within muscle cells, compared to controls.&#xD;
&#xD;
           ii. Exercise-induced improvements in insulin sensitivity of older men and women will be&#xD;
           related to the changes in muscle fat content independent of changes in total body fat or&#xD;
           visceral abdominal adipose tissue.&#xD;
&#xD;
        2. To determine whether increased capacity for oxidative fatty acid metabolism within&#xD;
           muscle results in improved insulin sensitivity in older adults. We will test two&#xD;
           hypotheses.&#xD;
&#xD;
           i. Exercise training will increase the capacity of muscle to oxidize fatty acids&#xD;
           assessed both in vitro and in vivo.&#xD;
&#xD;
           ii. Improved capacity for oxidative fatty acid metabolism will predict improvements in&#xD;
           insulin sensitivity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity and muscle fat content will be measured at the beginning and the end of the intervention to determine the effects of exercise on these measures.</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Examine if exercise-induced improvements in insulin sensitivity are similar in normal weight and in obese older subjects.</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise Group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Education Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Group</intervention_name>
    <description>Sixteen week intervention where subjects will be progressed to four days per week for 45 minutes per session, 180 minutes minimum per week, of moderate intensity supervised exercise.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Education Group</intervention_name>
    <description>Sixteen week intervention. This group will not receive specific exercise education or prescription but will be asked to participate in biweekly health education sessions</description>
    <arm_group_label>Health Education Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  60 - 70 years of age&#xD;
&#xD;
          -  No weight gain/loss of &gt;10 lbs in 6 months&#xD;
&#xD;
          -  Sedentary (No more than 1 continuous exercise/week) or Highly trained (&gt;5 exercise&#xD;
             sessions/week for a duration of one year or more)&#xD;
&#xD;
          -  Non-Smoker&#xD;
&#xD;
          -  BMI 18-38.0&#xD;
&#xD;
          -  Resting blood pressure less than 150mmHg systolic/95 mmHg diastolic&#xD;
&#xD;
          -  Normal glucose tolerance: Fasting glucose &lt; 100 mg/dl or 2 hour glucose from OGTT &lt;&#xD;
             140 mg/dl or impaired glucose tolerance (fasting glucose &gt; 100 mg/dl &lt; 126 mg/dl or 2&#xD;
             hour glucose from OGTT &gt; 140 mg/dl but less than 200 mg/dl&#xD;
&#xD;
          -  Note from PCP/Cardiologist for exercise clearance if positive stress test symptoms&#xD;
             were observed from GXT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically significant CVD including h/o MI&#xD;
&#xD;
          -  Peripheral Vascular Disease&#xD;
&#xD;
          -  Hepatic, renal, muscular/neuromuscular, or active hematologic/oncologic disease&#xD;
&#xD;
          -  Clinically diminished pulse&#xD;
&#xD;
          -  Presence of bruits in lower extremities&#xD;
&#xD;
          -  Previous history of pulmonary emboli&#xD;
&#xD;
          -  Peripheral Neuropathy&#xD;
&#xD;
          -  Currently not engaged in a regular program and have a V)2 max pre-training value &gt; 55&#xD;
             ml/kg-fat free mass-min., indicative of moderate fitness OR currently engaged in&#xD;
             regular program and having a V)2 max value &lt; 55 ml/kg-fat free mass-min.&#xD;
&#xD;
          -  Anemia (Hematocrit &lt; 34%)&#xD;
&#xD;
          -  Any contraindications to moderate exercise&#xD;
&#xD;
          -  Inability and/or willingness to comply with the protocol as written&#xD;
&#xD;
          -  Active alcohol or substance abuse (Past 5 years)&#xD;
&#xD;
          -  Total cholesterol &gt; 300 mg/dL&#xD;
&#xD;
          -  Triglyceride &gt; 350 mg/dL&#xD;
&#xD;
          -  ALT &gt; 80, AST &gt; 80, Alk Phos &gt; 240&#xD;
&#xD;
          -  Proteinuria (defined as &gt; 1+ on routine dipstick) hypothyroidism (sTSH&gt;8)&#xD;
&#xD;
          -  Therapeutic Doses of Nicotinic Acid&#xD;
&#xD;
          -  Type 2 Diabetes: Fasting Glucose &gt; 126 mg/dl or 2 hour glucose &gt; 200 mg/dl&#xD;
&#xD;
          -  Oral Glucocorticoids&#xD;
&#xD;
          -  Females currently on hormone replacement therapy (HRT) less than 6 months&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Previous difficulty with lidocaine or other local anesthetic&#xD;
&#xD;
          -  Stress test symptoms:&#xD;
&#xD;
               -  Positive ECG (&gt;2mm ST segment depression) without PCP cardiologist permission to&#xD;
                  participate&#xD;
&#xD;
               -  Signs or symptoms of cardiovascular decomposition (hypotensive response to&#xD;
                  exercise&#xD;
&#xD;
               -  Onset of angina or angina like symptoms, shortness of breath, change in heart&#xD;
                  rhythm, signs of poor perfusion (light-headedness), tightness&#xD;
&#xD;
               -  Hypotension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bret H. Goodpaster, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>October 2, 2008</study_first_submitted>
  <study_first_submitted_qc>October 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2008</study_first_posted>
  <last_update_submitted>February 3, 2018</last_update_submitted>
  <last_update_submitted_qc>February 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Erin E. Kershaw, M.D.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Insulin Resistance</keyword>
  <keyword>Obesity</keyword>
  <keyword>Exercise Training</keyword>
  <keyword>Physical Activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

